Testing the effectiveness of Botox using advanced cell culture techniques
Official title: High-Throughput NMJ Assay for Botox Potency Screening
Funded at Curi Bio INC · NIH-11001984 · Data updated 2026-11-12
This study is looking to create a new way to test how well Botox works by using special lab-grown nerve and muscle cells that act like those in our bodies, which could help improve treatments for conditions that Botox is used for.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Curi Bio INC NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | August 1, 2023 |
| Project end | January 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $901,175 |
| NIH project number | 5U44TR004795-03 |
| Project ID | NIH-11001984 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who require Botox for medical or cosmetic purposes and are interested in the underlying mechanisms of its action.
✕Less likely to help
Patients who do not use Botox or have contraindications for its use may not benefit from this research.
What this research studies
This research focuses on developing a high-throughput assay to evaluate the potency of botulinum toxin (Botox) using engineered systems that mimic human neuromuscular junctions. By utilizing human induced pluripotent stem cell-derived motor neurons and muscle cells, the study aims to create a reliable in vitro platform that can assess how Botox affects these cells in real-time. The approach involves co-culturing these cells and employing advanced techniques to stimulate neuronal activity and measure muscle contractions, which will help in understanding the efficacy and safety of Botox treatments. This innovative method could lead to improved drug development and better therapeutic strategies for conditions treated with Botox.
Why it matters
Potential benefit: If successful, this research could enhance the safety and effectiveness of Botox treatments for patients.
How similar studies have gone: Other research has shown promise in using engineered systems for drug potency testing, indicating that this approach could be effective.
Where this research is happening
-
Curi Bio INC
Seattle, United States Active
Researchers
- Principal investigator: Geisse, Nicholas Andrew — Curi Bio INC
- Study coordinator: Geisse, Nicholas Andrew
Related research
Other NIH-funded projects on the same topics.
-
Developing a new platform to test treatments for Duchenne muscular dystrophy
This study is working on better ways to test new treatments for Duchenne muscular dystrophy (DMD) by creating models that more closely resemble how human muscles work, so we can find effective therapies for boys with this condition.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.